Internal Medicine, Hematology & Oncology · New York, NY
NPI
1174962146
Since 2013
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
520 E 70th St # 341
New York, NY, 10021
Phone (646) 962-2700
Groups this clinician bills Medicare through
Medicare paid, 2024
$54K
543 services
Medicare patients, 2024
151
Average age 74
Drug cost, 2024
$3.8M
358 prescriptions
Company payments, 2025
$4,629
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ghaith F Abu Zeinah was code 99214 (office e&m - established), 255 times for 92 patients. In total Ghaith F Abu Zeinah billed 543 services in 17 codes, and Medicare paid $54K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-07-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 255 | 92 | $81.38 | $21K |
| 99215 Office E&M - Established | Facility | 178 | 69 | $126.66 | $23K |
| 99213 Office E&M - Established | Facility | 21 | 18 | $55.97 | $1,175 |
| 99205 Office E&M - New | Facility | 17 | 17 | $163.90 | $2,786 |
| 38222 Other Organ Systems | Facility | 15 | 15 | $65.21 | $978 |
By year: 2022 $61K for 573 services; 2023 $60K for 600 services; 2024 $54K for 543 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ghaith F Abu Zeinah prescribed most often to Medicare patients was Pegasys (Peginterferon Alfa-2a), with 92 prescriptions and refills. In total Ghaith F Abu Zeinah wrote 358 Medicare prescriptions that cost $3.8M.
Brand drugs: 289 claims; generic drugs: 69 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ghaith F Abu Zeinah $4,629 ($4,629 in general payments such as food, travel and fees) from 3 companies. The largest payer was Takeda Pharmaceuticals U.S.A., Inc. with $4,489.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.